ClinicalTrials.govpublic full text
A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
chronic spontaneous urticaria (csu), btk inhibitor, chronic spontaneous urticaria, urticaria activity score, hives severity score, itch severity score, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 825951
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.